BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 27128676)

  • 1. The Combined Deficiency of Immunoproteasome Subunits Affects Both the Magnitude and Quality of Pathogen- and Genetic Vaccination-Induced CD8+ T Cell Responses to the Human Protozoan Parasite Trypanosoma cruzi.
    Ersching J; Vasconcelos JR; Ferreira CP; Caetano BC; Machado AV; Bruna-Romero O; Baron MA; Ferreira LR; Cunha-Neto E; Rock KL; Gazzinelli RT; Rodrigues MM
    PLoS Pathog; 2016 Apr; 12(4):e1005593. PubMed ID: 27128676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoproteasome Subunits Are Required for CD8
    Guimarães G; Gomes MTR; Campos PC; Marinho FV; de Assis NRG; Silveira TN; Oliveira SC
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical contribution of immunoproteasomes in the induction of protective immunity against Trypanosoma cruzi in mice vaccinated with a plasmid encoding a CTL epitope fused to green fluorescence protein.
    Chou B; Hisaeda H; Shen J; Duan X; Imai T; Tu L; Murata S; Tanaka K; Himeno K
    Microbes Infect; 2008 Mar; 10(3):241-50. PubMed ID: 18321749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity.
    Eickhoff CS; Zhang X; Vasconcelos JR; Motz RG; Sullivan NL; O'Shea K; Pozzi N; Gohara DW; Blase JR; Di Cera E; Hoft DF
    PLoS Pathog; 2016 Sep; 12(9):e1005896. PubMed ID: 27642757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of antigen-specific B cells results in decreased Trypanosoma cruzi systemic but not mucosal immunity due to CD8 T cell exhaustion.
    Sullivan NL; Eickhoff CS; Sagartz J; Hoft DF
    J Immunol; 2015 Feb; 194(4):1806-18. PubMed ID: 25595788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic immunization based on the ubiquitin-fusion degradation pathway against Trypanosoma cruzi.
    Chou B; Hiromatsu K; Hisaeda H; Duan X; Imai T; Murata S; Tanaka K; Himeno K
    Biochem Biophys Res Commun; 2010 Feb; 392(3):277-82. PubMed ID: 20059980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8(+) T effector memory cells specific for a human parasite, Trypanosoma cruzi.
    Rigato PO; de Alencar BC; de Vasconcelos JR; Dominguez MR; Araújo AF; Machado AV; Gazzinelli RT; Bruna-Romero O; Rodrigues MM
    Infect Immun; 2011 May; 79(5):2120-30. PubMed ID: 21357719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogen-induced proapoptotic phenotype and high CD95 (Fas) expression accompany a suboptimal CD8+ T-cell response: reversal by adenoviral vaccine.
    Vasconcelos JR; Bruña-Romero O; Araújo AF; Dominguez MR; Ersching J; de Alencar BC; Machado AV; Gazzinelli RT; Bortoluci KR; Amarante-Mendes GP; Lopes MF; Rodrigues MM
    PLoS Pathog; 2012; 8(5):e1002699. PubMed ID: 22615561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.
    Gupta S; Garg NJ
    PLoS Negl Trop Dis; 2010 Aug; 4(8):e797. PubMed ID: 20706586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection with Trypanosoma cruzi restricts the repertoire of parasite-specific CD8+ T cells leading to immunodominance.
    Tzelepis F; de Alencar BC; Penido ML; Claser C; Machado AV; Bruna-Romero O; Gazzinelli RT; Rodrigues MM
    J Immunol; 2008 Feb; 180(3):1737-48. PubMed ID: 18209071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene.
    Fujimura AE; Kinoshita SS; Pereira-Chioccola VL; Rodrigues MM
    Infect Immun; 2001 Sep; 69(9):5477-86. PubMed ID: 11500420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination.
    de Alencar BC; Persechini PM; Haolla FA; de Oliveira G; Silverio JC; Lannes-Vieira J; Machado AV; Gazzinelli RT; Bruna-Romero O; Rodrigues MM
    Infect Immun; 2009 Oct; 77(10):4383-95. PubMed ID: 19651871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection.
    Miyahira Y; Takashima Y; Kobayashi S; Matsumoto Y; Takeuchi T; Ohyanagi-Hara M; Yoshida A; Ohwada A; Akiba H; Yagita H; Okumura K; Ogawa H
    Infect Immun; 2005 Nov; 73(11):7356-65. PubMed ID: 16239534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells.
    Rosenberg CS; Zhang W; Bustamante JM; Tarleton RL
    Infect Immun; 2016 Sep; 84(9):2627-38. PubMed ID: 27354447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
    Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
    Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental Nanovaccine Offers Protection Against Repeat Exposures to
    Chowdhury IH; Lokugamage N; Garg NJ
    Front Immunol; 2020; 11():595039. PubMed ID: 33414785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells.
    Limon-Flores AY; Cervera-Cetina R; Tzec-Arjona JL; Ek-Macias L; Sánchez-Burgos G; Ramirez-Sierra MJ; Cruz-Chan JV; VanWynsberghe NR; Dumonteil E
    Vaccine; 2010 Oct; 28(46):7414-9. PubMed ID: 20850536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of antigenic candidates by a DNA/MVA heterologous approach elicits effector CD8(+)T cell mediated immunity against Trypanosoma cruzi.
    Gupta S; Garg NJ
    Vaccine; 2012 Nov; 30(50):7179-86. PubMed ID: 23079191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P47phox-/- mice are compromised in expansion and activation of CD8+ T cells and susceptible to Trypanosoma cruzi infection.
    Dhiman M; Garg NJ
    PLoS Pathog; 2014 Dec; 10(12):e1004516. PubMed ID: 25474113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8(+) T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients.
    Egui A; Thomas MC; Morell M; Marañón C; Carrilero B; Segovia M; Puerta CJ; Pinazo MJ; Rosas F; Gascón J; López MC
    Mol Immunol; 2012 Oct; 52(3-4):289-98. PubMed ID: 22750229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.